RESUMO
BACKGROUND: Multi-level marketing (MLM) of nutrition products has experienced dramatic growth in recent decades. 'Wellness' is the second most popular niche in the MLM industry and represents 35% of sales among all the products in 2016. This category includes dietary supplements, weight management and sports nutrition products. The aim of this paper is to analyse whether this practice is legal and ethical. METHODS: An analysis of available documentary information about the legal aspects of Multi-level marketing business was performed. Ethical reflexion was based on the "principlism" approach. RESULTS: We argue that, while being a controversial business model, MLM is not fraudulent from a legal point of view. However, it is an unethical strategy obviating all the principles of beneficence, nonmaleficence and autonomy. What is at stake is the possible economic scam and the potential harm those products could cause due to unproven efficacy, exceeding daily nutrient requirements and potential toxicity. The sale of dietary and nutrition supplements products by physicians and dieticians presents a conflict of interests that can undermine the primary obligation of physicians to serve the interests of their patients before their own. CONCLUSION: While considering that MLM of dietary supplements and other nutrition products are a legal business strategy, we affirm that it is an unethical practice. MLM products that have nutritional value or promoted as remedies may be unnecessary and intended for conditions that are unsuitable for self-prescription as well.
Assuntos
Comércio/ética , Comércio/legislação & jurisprudência , Suplementos Nutricionais , Publicidade Direta ao Consumidor/ética , Publicidade Direta ao Consumidor/legislação & jurisprudência , Ética nos Negócios , Indústria Alimentícia/ética , Indústria Alimentícia/legislação & jurisprudência , Marketing de Serviços de Saúde/ética , Marketing de Serviços de Saúde/legislação & jurisprudência , Conflito de Interesses/legislação & jurisprudência , Fraude/ética , Fraude/legislação & jurisprudência , Regulamentação Governamental , Humanos , Formulação de Políticas , Revelação da Verdade/éticaRESUMO
Psychiatric medication, or psychotropics, are increasingly prescribed for people of all ages by both psychiatry and primary care doctors for a multitude of mental health and/or behavioral disorders, creating a sharp rise in polypharmacy (i.e., multiple medications). This paper explores the clinical reality of modern psychotropy at the level of the prescribing doctor and clinical exchanges with patients. Part I, Geographies of High Prescribing, documents the types of factors (pharmaceutical-promotional, historical, cultural, etc.) that can shape specific psychotropic landscapes. Ethnographic attention is focused on high prescribing in Japan in the 1990s and more recently in the Upper Peninsula of Michigan, in the US. These examples help to identify factors that have converged over time to produce specific kinds of branded psychotropic profiles in specific locales. Part II, Pharmaceutical Detox, explores a new kind of clinical work being carried out by pharmaceutically conscious doctors, which reduces the number of medications being prescribed to patients while re-diagnosing their mental illnesses. A high-prescribing psychiatrist in southeast Wisconsin is highlighted to illustrate a kind of med-checking taking place at the level of individual patients. These various examples and cases call for a renewed emphasis by anthropology to critically examine the "total efficacies" of modern pharmaceuticals and to continue to disaggregate mental illness categories in the Boasian tradition. This type of detox will require a holistic approach, incorporating emergent fields such as neuroanthropology and other kinds of creative collaborations.
Assuntos
Comportamento Aditivo/prevenção & controle , Indústria Farmacêutica , Prescrição Inadequada/prevenção & controle , Transtornos Mentais , Psicotrópicos/uso terapêutico , Antropologia Médica , Cumplicidade , Indústria Farmacêutica/economia , Indústria Farmacêutica/ética , Etnopsicologia/métodos , Saúde Holística , Humanos , Marketing de Serviços de Saúde/ética , Transtornos Mentais/diagnóstico , Transtornos Mentais/tratamento farmacológico , Transtornos Mentais/psicologia , Padrões de Prática Médica/ética , Medicamentos sob Prescrição/economia , Medicamentos sob Prescrição/uso terapêutico , Psicotrópicos/economia , Sociologia Médica , Estados UnidosAssuntos
Publicidade , Terapias Complementares , Marketing de Serviços de Saúde , Meios de Comunicação de Massa , Oncologia , Publicidade/ética , Publicidade/normas , Publicidade/tendências , Fidelidade a Diretrizes , Humanos , Hungria , Disseminação de Informação , Marketing de Serviços de Saúde/ética , Marketing de Serviços de Saúde/normas , Marketing de Serviços de Saúde/tendências , Meios de Comunicação de Massa/ética , Meios de Comunicação de Massa/normas , Meios de Comunicação de Massa/tendências , Oncologia/ética , Oncologia/métodos , Oncologia/normas , Oncologia/tendências , Pacientes/psicologia , Guias de Prática Clínica como Assunto , Marketing Social/éticaRESUMO
Research into the biological properties and clinical potential of stem cells has spurred strong public investment, industry development, media coverage, and patient interest in recent years. To date, however, few clinical applications of demonstrated safety and efficacy have been developed with the exception of uses of hematopoietic stem cells in the treatment of diseases of the blood and immune systems. This lack of an evidence basis notwithstanding, hundreds of companies and private clinics around the world now sell putative stem cell treatments for an enormously broad range of medical and quality-of-life conditions. This represents a major challenge for legitimate scientists working in the field, for authorities seeking to protect their constituencies, and for patients and consumers targeted by such companies' marketing strategies. In this review, I provide an overview of the global industry in pseudomedical stem cell treatments, with an investigation of claims in a single disease area (amyotrophic lateral sclerosis), and make recommendations for the introduction and enforcement of appropriate regulatory responses to this problem.
Assuntos
Esclerose Lateral Amiotrófica/economia , Marketing de Serviços de Saúde/economia , Transplante de Células-Tronco/economia , Células-Tronco/citologia , Esclerose Lateral Amiotrófica/terapia , Terapias Complementares/economia , Terapias Complementares/ética , Terapias Complementares/legislação & jurisprudência , Medicina Baseada em Evidências/economia , Medicina Baseada em Evidências/legislação & jurisprudência , Medicina Baseada em Evidências/normas , Fraude/economia , Fraude/prevenção & controle , Saúde Global , Regulamentação Governamental , Política de Saúde , Humanos , Internacionalidade , Marketing de Serviços de Saúde/ética , Marketing de Serviços de Saúde/legislação & jurisprudência , Transplante de Células-Tronco/ética , Transplante de Células-Tronco/legislação & jurisprudênciaRESUMO
Social justice in public health involves the process and product of a community acting to fairly distribute advantages and burdens to improve the health of its population and to reasonably take care of the disadvantaged. Although publications are available about chiropractic public health history, programs, and policy, the potential role of chiropractic in social justice has received little attention. This article discusses Beauchamp's 4 principles of social justice and suggests actions that the chiropractic profession may consider to participate in the practice of social justice in the field of public health.
Assuntos
Quiroprática/ética , Marketing de Serviços de Saúde/ética , Saúde Pública/ética , Justiça Social , Disparidades em Assistência à Saúde/ética , Humanos , Ética Baseada em PrincípiosRESUMO
Genomics researchers and policy makers have accused nutrigenetic testing companies--which provide DNA-based nutritional advice online--of misleading the public. The UK and USA regulation of the tests has hinged on whether they are classed as "medical" devices, and alternative regulatory categories for "lifestyle" and less-serious genetic tests have been proposed. This article presents the findings of a qualitative thematic analysis of the webpages of nine nutrigenetic testing companies. We argue that the companies, mirroring and negotiating the regulatory debates, were creating a new social space for products between medicine and consumer culture. This space was articulated through three themes: (i) how "genes" and tests were framed, (ii) how the individual was imagined vis a vis health information, and (iii) the advice and treatments offered. The themes mapped onto four frames or models for genetic testing: (i) clinical genetics, (ii) medicine, (iii) intermediate, and (iv) lifestyle. We suggest that the genomics researchers and policy makers appeared to perform what Gieryn (Gieryn, T.F. (1983). Boundary-work and the demarcation of science from non-science: strains and interests in professional ideologies of scientists. American Sociological Review, 48, 781-795.) has termed "boundary work", i.e., to delegitimize the tests as outside proper medicine and science. Yet, they legitimated them, though in a different way, by defining them as lifestyle, and we contend that the transformation of the boundaries of science into a creation of such hybrid or compromise categories is symptomatic of current historical times. Social scientists studying medicine have referred to the emergence of "lifestyle" products. This article contributes to this literature by examining the historical, regulatory and marketing processes through which certain goods and services become defined this way.
Assuntos
Informação de Saúde ao Consumidor/ética , Testes Genéticos , Internet , Marketing de Serviços de Saúde , Nutrigenômica , Comércio/ética , Comércio/métodos , Pesquisa em Genética , Testes Genéticos/legislação & jurisprudência , Regulamentação Governamental , Política de Saúde , Humanos , Estilo de Vida , Marketing de Serviços de Saúde/ética , Marketing de Serviços de Saúde/métodos , Nutrigenômica/organização & administração , Formulação de Políticas , Pesquisa Qualitativa , Reino Unido , Estados UnidosRESUMO
The current popularity of complementary/alternative medicine (CAM) generates many challenges to medical ethics. The one discussed here is the advice offered by CAM practitioners. Using selected examples, the author tries to demonstrate that some of the advice issued through the popular media or provided by acupuncturists, chiropractors, herbalists, homeopaths, pharmacists, and doctors is misleading or dangerous. This, the author argues, can impinge on the main principle of medical ethics: beneficence, nonmaleficence, and autonomy. We should work toward correcting this deplorable situation.
Assuntos
Terapias Complementares/ética , Informação de Saúde ao Consumidor/ética , Beneficência , Enganação , Humanos , Marketing de Serviços de Saúde/ética , ConfiançaRESUMO
The pace of social change in Thailand has seen the rise of various medical services and a global clientele. Currently, medical tourism and cosmetic surgery have an important role in medical practice here. A growing medical market offers a range of services at competitive rates and high levels of efficiency. This essay provides an overview of medical practices in Thailand and their effect on ordinary people.
Assuntos
Filosofia Médica , Padrões de Prática Médica , Mudança Social , Cirurgia Plástica , Atitude do Pessoal de Saúde/etnologia , Atitude Frente a Saúde/etnologia , Budismo , Competição Econômica , Eficiência Organizacional , Saúde Global , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Marketing de Serviços de Saúde/ética , Marketing de Serviços de Saúde/organização & administração , Medicina Tradicional Chinesa/tendências , Inovação Organizacional , Padrões de Prática Médica/ética , Padrões de Prática Médica/organização & administração , Valores Sociais , Cirurgia Plástica/ética , Cirurgia Plástica/organização & administração , Tailândia , Viagem/ética , Viagem/tendências , OcidenteAssuntos
Publicidade/ética , Terapias Complementares/ética , Técnicas Cosméticas/ética , Marketing de Serviços de Saúde/ética , Ritidoplastia/ética , Códigos de Ética , Conflito Psicológico , Técnicas Cosméticas/enfermagem , Técnicas Cosméticas/psicologia , Cosméticos/normas , Ética Médica , Ética em Enfermagem , Medicina Baseada em Evidências , Humanos , Consentimento Livre e Esclarecido/ética , Intuição , Princípios Morais , Relações Médico-Paciente , Guias de Prática Clínica como Assunto , Rejuvenescimento/psicologia , Ritidoplastia/enfermagem , Ritidoplastia/psicologia , Envelhecimento da Pele/efeitos dos fármacos , Envelhecimento da Pele/ética , Confiança , Revelação da Verdade/éticaRESUMO
This paper deals with the ethics of marketing medical services by physicians, medical groups, hospitals and other mainstream medical caregivers in the United States. It does not deal with pharmaceutical marketing, since that raises a number of special issues, some of them legal and some having to do with the unique culture of pharmaceutical marketing, which really ought to be dealt with separately. Nor does it touch on the little-explored field of marketing alternative and complementary medicine. It begins with a general description of what is included in "the marketing process." It then briefly tours some of the difficulties faced by those who would market medical services ethically, and ends with some comments on the relevance of professionalism to ethical marketing.